
ALLO EPS Estimates
Allogene Therapeutics, Inc.
$0.67
-$0.03(-4.34%)
33
Overall
60
Value
18
Tech
21
Quality
Market Cap
$230.64M
Volume
6.00M
52W Range
$0.82 - $4.46
Target Price
$8.30
ALLO EPS estimates: the consensus estimate for Allogene Therapeutics, Inc.'s current fiscal year is -$0.58 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
ALLO EPS Estimates
- EPS estimate, current quarter
- $-0.15
- EPS estimate, next quarter
- $-0.15
- EPS estimate, current year
- $-0.58
- EPS estimate, next year
- $-0.61
- EPS growth, 3-year
- +0.00%
| Fiscal year | EPS |
|---|---|
| 2022 | $-2.32 |
| 2021 | $-1.89 |
| 2020 | $-2.08 |
| 2019 | $-1.83 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ALLO | $0.67 | -4.3% | 6.00M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Allogene Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW